CG Oncology, Inc. (CGON)
62.22
+0.29
(+0.47%)
USD |
NASDAQ |
Oct 21, 16:00
62.22
0.00 (0.00%)
After-Hours: 17:08
CG Oncology EPS Diluted (Quarterly) : -0.8963 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.8963 |
| March 31, 2026 | -0.7123 |
| December 31, 2025 | -0.5157 |
| September 30, 2025 | -0.5709 |
| June 30, 2025 | -0.5435 |
| March 31, 2025 | -0.4522 |
| December 31, 2024 | -0.4175 |
| September 30, 2024 | -0.3021 |
| Date | Value |
|---|---|
| June 30, 2024 | -0.2836 |
| March 31, 2024 | -0.3598 |
| December 31, 2023 | -0.3309 |
| September 30, 2023 | -0.2694 |
| June 30, 2023 | -0.2309 |
| March 31, 2023 | -0.1861 |
| December 31, 2022 | -0.1825 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -1.355 |
| Oncolytics Biotech, Inc. | -0.0788 |
| Sangamo Therapeutics, Inc. | -0.0796 |
| Sarepta Therapeutics, Inc. | -0.0464 |
| Anixa Biosciences, Inc. | -0.0762 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -79.06M |
| Revenue (Quarterly) | 1.157M |
| Total Expenses (Quarterly) | 80.21M |
| Enterprise Value | 4.449B |
| Gross Profit Margin (Quarterly) | -239.2% |
| Profit Margin (Quarterly) | -6.83K% |
| Earnings Yield | -4.33% |
| Normalized Earnings Yield | -4.332 |